Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
ORX-750 by Centessa Pharmaceuticals for Type 1 Narcolepsy (Narcolepsy with Cataplexy): Likelihood of Approval
ORX-750 is under clinical development by Centessa Pharmaceuticals and currently in Phase II for Type 1 Narcolepsy (Narcolepsy with Cataplexy)....